Thrombin: Beyond coagulation

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 1, 2004, Pages 13-15

  Weber, D S ^a   Griendling, K K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; ANTIOXIDANT; BASIC FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; THROMBIN; THROMBIN INHIBITOR; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFECT; EDITORIAL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBUS; VASCULAR SMOOTH MUSCLE;

THROMBUS;

EID: 0345743547     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2003.10.009     Document Type: Editorial

References (23)

1. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 97:1996;1916-1923.
2. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 99:1999;2027-2033.
3. Souza H.P., Souza L.C., Anastacio V.M., Pereira A.C., Junqueira M.L., Krieger J.E., et al. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med. 28:2000;1232-1242.
4. Szöcs K., Lassègue B., Sorescu D., Hilenski L.L., Valppu L., Couse T.L., et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol. 22:2002;21-27.
5. 2- production in the pig coronary artery. Circulation. 96:1997;3593-3601.
6. Moser M., Patterson C. Thrombin and vascular development: a sticky subject. Arterioscler Thromb Vasc Biol. 23:2003;922-930.
7. Major C.D., Santulli R.J., Derian C.K., Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol. 23:2003;931-939.
8. Andrade-Gordon P., Derian C.K., Maryanoff B.E., Zhang H.C., Addo M.F., Cheung W., et al. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther. 298:2001;34-42.
9. Chen X., Ren S., Ma M.G., Dharmalingam S., Lu L., Xue M., et al. Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits. Atherosclerosis. 169:2003;31-40.
10. Cucina A., Borrelli V., Lucarelli M., Sterpetti A.V., Cavallaro A., Strom R., et al. Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells. Cell Biochem Funct. 20:2002;39-46.
11. Kalmes A., Vesti B.R., Daum G., Abraham J.A., Clowes A.W. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res. 87:2000;92-98.
12. Wang Z, Castresana MR, Newman WH. Reactive oxygen species-sensitive p38 MAPK controls thrombin-induced migration of vascular smooth muscle cells. J Mol Cell Cardiol 2004;36(1):49-56, in this issue.
13. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
14. Kanda Y., Nishio E., Kuroki Y., Mizuno K., Watanabe Y. Thrombin activates p38 mitogen-activated protein kinase in vascular smooth muscle cells. Life Sci. 68:2001;1989-2000.
15. Iijima K., Yoshizumi M., Hashimoto M., Akishita M., Kozaki K., Ako J., et al. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation. 105:2002;2404-2410.
16. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol. 23:2003;795-801.
17. Ushio-Fukai M., Alexander R.W., Akers M., Griendling K.K. MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem. 273:1998;15022-15029. p38.
18. Griendling K.K., Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 91:2000;21-27.
19. Bassus S., Herkert O., Kronemann N., Gorlach A., Bremerich D., Kirchmaier C.M., et al. Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species. Arterioscler Thromb Vasc Biol. 21:2001;1550-1555.
20. Sato Y., Asada Y., Marutsuka K., Hatakeyama K., Kamikubo Y., Sumiyoshi A. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Haemost. 78:1997;1138-1141.
21. Rousseau S., Houle F., Huot J. Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trend Cardiovasc Med. 10:2000;321-327.
22. Zachary I., Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 49:2001;568-581.
23. Khatri J.J., Dikalov S., Harrison D.G., Galis Z.S. Oxidative stress triggers angiogenesis in experimental atheroma. Circulation. 106:2003;II-285.